Retrospective observational cohort study evaluating changes in oral anticoagulation therapy over one year in patients with Atrial Fibrillation
Latest Information Update: 28 Mar 2019
At a glance
- Drugs Apixaban (Primary) ; Dabigatran etexilate (Primary) ; Rivaroxaban (Primary) ; Vitamin K antagonists (Primary)
- Indications Atrial fibrillation
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 28 Mar 2019 New trial record
- 12 Mar 2019 Results published in the Thrombosis and Haemostasis